| Compound ID |
Compound Name |
Compound Formula |
|
CP0641297
|
N-(5-ethyl-3-isoxazolyl)-N'-[4-(2-[6-(4-ethylpiperazino)-2-methyl-4-pyrimidinyl]amino-1,3-thiazol-5-yl)phenyl]urea
Show/Hide
|
C26H31N9O2S
|
1
|
| 1 |
GI50 = 110 nM
|
|
|
|
CP0016677
|
N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
Show/Hide
|
C35H30N4O4
|
3
|
| 1 |
GI50 = 400 nM
|
|
|
| 2 |
IC50 = 13 nM
|
|
|
| 3 |
IC50 = 15 nM
|
|
|
|
CP0030740
|
1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morpholin-4-Yl)ethoxy]imidazo[2,1-B][1,3]benzothiazol-2-Yl}phenyl)urea
Show/Hide
|
C29H32N6O4S
|
3
|
| 1 |
GI50 = 2200 nM
|
|
|
| 2 |
IC50 = 1.1 nM
|
|
|
| 3 |
IC50 = 4.2 nM
|
|
|
|
CP0018477
|
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
Show/Hide
|
C21H16ClF3N4O3
|
3
|
| 1 |
GI50 = 9300 nM
|
|
|
| 2 |
IC50 = 2 nM
|
|
|
| 3 |
IC50 = 3.2 nM
|
|
|
|
CP0034962
|
16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one
Show/Hide
|
C26H21N3O4
|
2
|
| 1 |
IC50 = 1.5 nM
|
|
|
| 2 |
IC50 = 2.6 nM
|
|
|
|
CP0002211
|
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
Show/Hide
|
C22H27FN4O2
|
2
|
| 1 |
IC50 = 9.9 nM
|
|
|
| 2 |
IC50 = 34 nM
|
|
|
|
CP0034949
|
4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
Show/Hide
|
C31H42N6O4
|
2
|
| 1 |
IC50 = 33 nM
|
|
|
| 2 |
IC50 = 170 nM
|
|
|
|
CP0034613
|
N-[(2S,3R,4R,6R,18S)-18-hydroxy-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
Show/Hide
|
C35H30N4O5
|
2
|
| 1 |
IC50 = 160 nM
|
|
|
| 2 |
IC50 = 350 nM
|
|
|
